Nozaki Katsuhiro, Nakao Koichi, Horiuchi Kenji, Kasanuki Hiroshi, Honda Takashi
Division of Cardiology, Cardiovascular Center, Saiseikai Kumamoto Hospital, Chikami 5-3-1, Kumamoto, Kumamoto 861-4193.
J Cardiol. 2003 Jun;41(6):263-70.
To assess the efficacy of early invasive strategy for the treatment of Braunwald III-B type unstable angina pectoris.
This study included 573 consecutive patients of whom 267 underwent percutaneous coronary intervention (PCI) (312 lesions). The patients were divided into two groups, 95 treated with the early invasive strategy of coronary angiography within 24 hr of admission (Group PCI-I) and the remaining 172 treated with the early conservative strategy of coronary angiography 24 hr after admission (Group PCI-C).
No significant differences were noted in the baseline characteristics of the two groups except for ST segment elevation on electrocardiography at presentation, which occurred significantly less frequently in Group PCI-C (36.8% vs 8.1%, p < 0.0001). The initial success rate of percutaneous coronary intervention was sufficiently high in both groups (Group PCI-I: 96.9% vs Group PCI-C: 97.7%, NS). Acute myocardial infarction occurred in six patients of Group PCI-C (3.5%) because of the side branch occlusion. There was no in-hospital death or emergent coronary artery bypass grafting. During the 6-month follow-up, there were no significant differences in the death rates (2.1% vs 1.7%), the death or myocardial infarction rates (5.3% vs 5.8%) and the target lesion revascularization ratio (26.0% vs 25.7%) between Group PCI-I and Group PCI-C.
The clinical outcomes of the early invasive strategy for unstable angina pectoris were almost equivalent to those of the early conservative strategy, despite more frequent ST segmental elevation at admission in Group PCI-I. These findings suggest that the early invasive strategy for unstable angina pectoris may be acceptable even in the current Japanese clinical setting without the use of GP IIb/IIIa receptor antagonist, low molecular weight heparin or clopidogrel.
评估早期有创策略治疗Braunwald III - B型不稳定型心绞痛的疗效。
本研究纳入573例连续患者,其中267例行经皮冠状动脉介入治疗(PCI)(312处病变)。患者分为两组,95例在入院24小时内接受冠状动脉造影早期有创策略治疗(PCI - I组),其余172例在入院24小时后接受冠状动脉造影早期保守策略治疗(PCI - C组)。
两组基线特征无显著差异,但PCI - C组入院时心电图ST段抬高发生率显著低于PCI - I组(36.8%对8.1%,p < 0.0001)。两组经皮冠状动脉介入治疗的初始成功率均足够高(PCI - I组:96.9%对PCI - C组:97.7%,无显著差异)。PCI - C组有6例患者(3.5%)因分支闭塞发生急性心肌梗死。无院内死亡或急诊冠状动脉搭桥手术。在6个月随访期间,PCI - I组和PCI - C组在死亡率(2.1%对1.7%)、死亡或心肌梗死率(5.3%对5.8%)以及靶病变血运重建率(26.0%对25.7%)方面无显著差异。
不稳定型心绞痛早期有创策略的临床结局与早期保守策略几乎相当,尽管PCI - I组入院时ST段抬高更频繁。这些发现表明,即使在当前日本临床环境中,不使用糖蛋白IIb/IIIa受体拮抗剂、低分子量肝素或氯吡格雷,不稳定型心绞痛的早期有创策略也可能是可接受的。